{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:09:03Z","timestamp":1767625743315,"version":"3.40.5"},"reference-count":65,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The prevalence of HIV and hepatitis B virus (HBV) co\u2010infection is higher in Asia than in Europe and North America and varies significantly between different regions within Asia. Important routes of transmission of both these infections include high\u2010risk unprotected sexual contact, intravenous drug use, and transmission of maternal infection perinatally or in early childhood. While life expectancy among people living with HIV has been extended with effective antiretroviral therapy (ART), HBV\u2010induced liver injury and complications have emerged as a leading cause of morbidity and mortality in people living with HIV.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>This article describes the prevalence of co\u2010infection, current clinical practice, and recommendations for the management of people living with HIV\u2010HBV co\u2010infection in Asia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results and Conclusions<\/jats:title><jats:p>Screening for HBV should occur at the time of HIV diagnosis; however, HBV screening rates in people living with HIV in Asia vary widely by region. Similarly, people with HBV should be screened for HIV before initiation of HBV antiviral therapy. People with HIV\u2010HBV co\u2010infection should be assessed for liver damage and risk factors for liver disease and be monitored regularly for liver complications and HBV DNA. Medical treatment with ART is lifelong and includes tenofovir and lamivudine or emtricitabine, unless intolerant or contraindicated, as these are active against both HIV and HBV. HBV vaccination programmes are effective in reducing co\u2010infection rates. Mother\u2010to\u2010child transmission can be prevented through measures such as vaccination, antenatal screening, and treatment of pregnant women who are infected.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hiv.13545","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T06:33:10Z","timestamp":1695364390000},"page":"1035-1044","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Current practice and recommendations for management of hepatitis B virus in people living with <scp>HIV<\/scp> in Asia"],"prefix":"10.1111","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5242-2967","authenticated-orcid":false,"given":"Grace Chung\u2010Yan","family":"Lui","sequence":"first","affiliation":[{"name":"Department of Medicine and Therapeutics The Chinese University of Hong Kong, Prince of Wales Hospital  Shatin Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2863-9389","authenticated-orcid":false,"given":"Grace Lai\u2010Hung","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics The Chinese University of Hong Kong, Prince of Wales Hospital  Shatin Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3864-9895","authenticated-orcid":false,"given":"Hung\u2010Chih","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine National Taiwan University Hospital  Taipei City Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5605-7853","authenticated-orcid":false,"given":"Wang\u2010Huei","family":"Sheng","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine National Taiwan University Hospital  Taipei City Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2093-3628","authenticated-orcid":false,"given":"Sun Hee","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Pusan National University Hospital, Pusan National University School of Medicine and Medical Research Institute  Busan South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13217"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13660"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13280"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22883"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.713981"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.745541"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1086\/420744"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001574"},{"key":"e_1_2_12_10_1","unstructured":"European AIDS Clinical Society.EACS Guidelines Version 11.1 October 2022. [cited 28 July 2023]; Available fromhttps:\/\/www.eacsociety.org\/media\/guidelines-11.1_final_09-10.pdf"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.3795"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001511"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-020-01404-z"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1159\/000252780"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e7"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2019.10.005"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31825eb0ad"},{"key":"e_1_2_12_18_1","unstructured":"World Health Organisation Western Pacific Region.Eliminating mother to child transmission of HIV hepatitis and syphilis.2022[cited 2022 25 July]. Available from:https:\/\/www.who.int\/westernpacific\/activities\/eliminating\u2010mother\u2010to\u2010child\u2010transmission\u2010of\u2010hiv\u2010hepatitis\u2010syphilis."},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/tme.12903"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2023.28.30.2200837"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1174638"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.05.044"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2219347"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2022.2115126"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1678728"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2019.06.003"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-015-9675-4"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2021.0305"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29800"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01313-07"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.664494"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/09564624221116530"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28280"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0084"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2015.960398"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.04.041"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2018.11.008"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1086\/597276"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1630"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12581"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.05.030"},{"volume-title":"Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach","year":"2016","author":"World Health Organization","key":"e_1_2_12_43_1"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169228"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.35772\/ghm.2019.01021"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000379"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-020-01698-4"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.10.035"},{"issue":"3","key":"e_1_2_12_49_1","first-page":"324","article-title":"3\u2010year treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil fumarate for chronic HBV infection in China","volume":"9","author":"Hou J","year":"2021","journal-title":"J Clin Transl Hepatol"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.01.035"},{"key":"e_1_2_12_51_1","article-title":"Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV\u20101 and hepatitis B coinfection (ALLIANCE): a double\u2010blind, multicentre, randomised controlled, phase 3 non\u2010inferiority trial","author":"Avihingsanon A","year":"2023","journal-title":"Lancet HIV"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30107-8"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30024-3"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002386"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13690-021-00693-2"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(12)70243-8"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1277844"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-019-0249-8"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw195"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000180"},{"key":"e_1_2_12_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit145"},{"volume-title":"Prevention of Mother\u2010to\u2010Child Transmission of Hepatitis B Virus: Guidelines on Antiviral Prophylaxis in Pregnancy","year":"2020","author":"World Health Organization","key":"e_1_2_12_62_1"},{"key":"e_1_2_12_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-067275"},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17120"},{"key":"e_1_2_12_65_1","unstructured":"World Health Organization.\u201cHepatitis B.\u201d Retrived 27 July 2022. from2022https:\/\/www.who.int\/news\u2010room\/fact\u2010sheets\/detail\/hepatitis\u2010b#:~:text=WHO%20recommends%20that%20all%20infants years%20and%20is%20probably%20lifelong"},{"key":"e_1_2_12_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2020.03.014"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.13545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T19:30:31Z","timestamp":1696534231000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hiv.13545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1111\/hiv.13545"],"URL":"https:\/\/doi.org\/10.1111\/hiv.13545","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"type":"print","value":"1464-2662"},{"type":"electronic","value":"1468-1293"}],"subject":[],"published":{"date-parts":[[2023,9,21]]},"assertion":[{"value":"2023-04-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}